1. Home
  2. AUDC vs CCCC Comparison

AUDC vs CCCC Comparison

Compare AUDC & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AudioCodes Ltd.

AUDC

AudioCodes Ltd.

HOLD

Current Price

$9.03

Market Cap

267.0M

Sector

Utilities

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.52

Market Cap

240.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUDC
CCCC
Founded
1992
2015
Country
Israel
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
267.0M
240.3M
IPO Year
1999
2020

Fundamental Metrics

Financial Performance
Metric
AUDC
CCCC
Price
$9.03
$2.52
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$11.67
$8.50
AVG Volume (30 Days)
115.6K
1.4M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
4.36%
N/A
EPS Growth
15.76
N/A
EPS
0.46
N/A
Revenue
$244,553,000.00
$30,108,000.00
Revenue This Year
$2.52
N/A
Revenue Next Year
$3.15
N/A
P/E Ratio
$19.83
N/A
Revenue Growth
0.15
N/A
52 Week Low
$8.01
$1.09
52 Week High
$12.72
$4.89

Technical Indicators

Market Signals
Indicator
AUDC
CCCC
Relative Strength Index (RSI) 53.45 49.41
Support Level $8.55 $2.50
Resistance Level $9.33 $2.69
Average True Range (ATR) 0.23 0.18
MACD 0.07 -0.01
Stochastic Oscillator 73.90 26.14

Price Performance

Historical Comparison
AUDC
CCCC

About AUDC AudioCodes Ltd.

AudioCodes Ltd develops and sells onverged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: